Hangzhou Aichek Medical Technology Co.,Ltd

Hangzhou Aichek Medical Technology Co.,Ltd

Manufacturer from China
Active Member
4 Years
Home / Products / Neutralizing Antibody Rapid Test /

One Step Ncov-19 Neutralization Antibody Detection Kit For Vaccination Evaluation

Contact Now
Hangzhou Aichek Medical Technology Co.,Ltd
City:hangzhou
Province/State:zhejiang
Country/Region:china
Contact Person:MrEdward YU
Contact Now

One Step Ncov-19 Neutralization Antibody Detection Kit For Vaccination Evaluation

Ask Latest Price
Video Channel
Brand Name :Aichek
Model Number :COVID-19-G02001A
Certification :CE
Place of Origin :China
MOQ :5000 Test
Price :negotiable
Payment Terms :T/T
Supply Ability :negotiable
Packaging Details :40box/carton
Storage :2℃-30℃
User :Everyone
Accuracy :96.6% (95% CI: 92.4%~100%).
Certificate :CE ISO 13485
Key words :One Step Ncov-19 Neutralizing Antibody Test Kits For Vaccination Evaluation
OEM :OEM customized packing avaliable
Formats :25T/box 1T/box
Sample :Blood
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

One Step Ncov-19 Neutralizing Antibody Test Kits For Vaccination Evaluation

For professional and in vitro diagnostic use only.

Product Name SARS-CoV-2 ISO13485 Rapid Neutralizing Antibody Test Kit 96.6%
Formats Strip(3mm)Device(4mm) uncut sheet
Place of Origen China
Specimen Blood
Read Time 15 minutes
Shelf life 2 years
Package 25T/Box
Storage 2℃-30℃

For professional and in vitro diagnostic use only.

[PERFORMANCE CHARACTERISTICS]

Sensitivity

The sensitivity to S-mIgG1 neutralizing antibody can reach 2ug/mL.

Accuracy

A side-by-side comparison was conducted by the results of SARS-Cov-2 Neutralizing Antibody Test Device (Test Reagent) developed by Hangzhou Deangel Biological Engineering Co., Ltd. and cPassTM from Genscript CO., Ltd. 328 clinical specimens from Professional Point of Care site were evaluated, 105 were positive and others negative. Base on the results from the clinical studies, the statistical analysis was made as follows:

cPassTM Total
Positive Negative

Test

reagent

Positive 96 2 98
Negative 9 221 230
Total 105 223 328

For test reagent, the clinical sensitivity with the “Compared Reagent” was 91.4% (95% CI: 77.7%~100%), the clinical specificity was 99.1% (95% CI: 97.2%~100%), the coincidence rate was 96.6% (95% CI: 92.4%~100%).

[LIMITATIONS]

  • The device is limited to provide a qualitative detection. The intensity of the test line does not necessarily correlate to the concentration of the antibody in the blood.

  • Each physician must interpret the results in conjunction with the patient’s history, physical findings, and other diagnostic procedures.

  • If symptoms persist and the result from the device is negative, it is recommended to collect a new sample from the patient a few days later and test it again.

  • A negative result can occur if the titer of antibodies against the SARS-CoV-2 virus present in the specimen is below the sensitivity of the assay.

  • Improper sample collection, improper sample storage or repeated freezing and thawing of samples can lead to inaccurate results.

[SUMMARY]

The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

One Step Ncov-19 Neutralization Antibody Detection Kit For Vaccination Evaluation

One Step Ncov-19 Neutralization Antibody Detection Kit For Vaccination Evaluation

Inquiry Cart 0